Prosecution Insights
Last updated: April 19, 2026

Shenzhen Rhegen Biotechnology Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18329015 Mannose-Based mRNA Targeted Delivery System and Use Thereof KELLY, ROBERT M 1638 Non-Final OA Jun 05, 2023
18022062 NOVEL 5'CAP ANALOG HAVING CAP2 STRUCTURE AND PREPARATION METHOD THEREFOR LEWIS, PATRICK T 1691 Non-Final OA Feb 17, 2023

Managing Shenzhen Rhegen Biotechnology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month